Where excludability matters: Material versus intellectual property in academic biomedical research

Research Policy

Volumn 36, Issue 8, 2007, Pages 1184-1203

  Walsh, John P ^a   Cohen, Wesley M ^b   Cho, Charlene ^c  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b DUKE UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY LAW SCHOOL   (United States)

Author keywords

Biomedical research; Excludability; Material transfers; Patents; Research tools

Indexed keywords

ENGINEERING RESEARCH; INTELLECTUAL PROPERTY; PATIENT TREATMENT;

EXCLUDABILITY; MATERIAL TRANSFERS; RESEARCH TOOLS;

BIOMEDICAL ENGINEERING;

EID: 34548666974     PISSN: 00487333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.respol.2007.04.006     Document Type: Article

References (42)

1. Andrews L., Paradise J., Holbrook T., and Bochneak D. When patents threaten science. Science 314 (2006) 1395-1396
2. Baeuerle P.A., and Baltimore D. NF-kB: ten years after. Cell 87 (1996) 13-20
3. Bekelman J.E., Li Y., and Gross C.P. Scope and impact of financial conflicts of interest in biomedical research. Journal of the American Medical Association 289 (2003) 454-465
4. Blumenthal, David E.G., Campbell M.S., Anderson, Causino N., and Louis K.S. Withholding research results in academic life science. Evidence from a national survey of faculty. Journal of the American Medical Association 277 (1997) 1224-1228
5. Campbell E.G., Clarridge B.R., Gokhale M., Birenbaum L., Hilgartner S., Holtzman N.A., and David B. Data withholding in academic genetics. Journal of the American Medical Association 287 (2002) 473-480
6. Cohen S. The isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in new-born animal. Journal of Biological Chemistry 237 (1962) 1555-1562
7. Cohen S. The epidermal growth factor (EGF). Cancer 51 (1983) 1787-1791
8. Cohen, W.M., Florida, R., Goe, R., 1994. University-Industry Research Centers in the United States, unpl. ms., Carnegie Mellon University.
9. Cole J.R., and Cole S. The Ortega hypothesis. Science 178 (1972) 368-375
10. Dasgupta P., and Maskin E. The simple economics of research portfolios. Economic Journal 97 (1987) 581-595
11. Dasgupta P., and David P.A. Toward a new economics of science. Research Policy 23 (1994) 487-521
12. Department of Health and Human Services, 1999. Principles and Guidelines for Recipients of NIH Research Grants and Contracts on Obstaining and Disseminating Biomedical Research Resources: Final Notice. Federal Register, December 23, pp. 72090-72096.
13. Eisenberg R.S. Bargaining over the transfer of proprietary research tools. In: Dreyfuss R.C., Zimmerman D.L., and First H. (Eds). Expanding the Boundaries of Intellectual Property (2001), Oxford University Press, Oxford 223-250
14. Eisenberg R.S. Patent swords and shields. Science 299 (2003) 1018-1019
15. Ellickson R. Order Without Law (1991), Cambridge, Harvard University
16. Hagstrom W.O. Competition in science. American Sociological Review 39 (1974) 1-18
17. Hansen, S.A., Korn, D., Chapman, A. 2005. AAU/AAMC/AAAS/COGR Survey-University Response: Post-Madey v. Duke. Presented in Fifth Meeting of the Committee on Intellectual Property Rights in Genomic and Protein-Related Inventions. National Academy of Sciences, Washington, DC.
18. Hausman J., Bronwyn H.H., and Zvi G. Econometric models for count data with an application to the patents-R&D relationship. Econometrica 52 (1984) 909-938
19. Heller M.A., and Eisenberg R.S. Can patents deter innovation? The anticommons in biomedical research. Science 280 (1998) 698-701
20. Kastan M.B., and Bartek J. Cell-cycle checkpoints and cancer. Nature 432 (2004) 316-323
21. Kristiansen O.P., Larsen Z.M., and Pociot F. CTLA-4 in autoimmune diseases-a general susceptibility gene to autoimmunity?. Genes Immunology 1 (2000) 170-184
22. Linsley P.S., Brady W., Urnes M., Grosmaire L.S., Damle N.K., and Ledbetter J.A. CTLA-4 is a second receptor for the B-cell activation antigen-B7. Journal of Experimental Medicine 174 (1991) 561-569
23. Merges R.P., and Nelson R.R. On the complex economics of patent scope. Columbia Law Review 90 (1990) 839-916
24. Merton R.K. The Sociology of Science (1973), The University of Chicago Press, Chicago
25. Mowery D.C., and Ziedonis A.A. Academic patents and material transfer agreements: substitutes or complements?. Journal of Technology Transfer 32 (2007) 157-172
26. Murray, F., Stern, S., 2005. Do formal intellectual property rights hinder the free flow of scientific knowledge: an empirical test of the anti-commons hypothesis. NBER Working Paper, vol. W11465.
27. National Research Council. Sharing Publication-Related Data and Materials: Responsibilities of Authorship in the Life Sciences (2003), National Academies Press, Washington, DC
28. National Research and Council. Trends in Patenting and Licensing of Genomic and Protein Inventions and Their Impact on Biomedical Research (2005), National Academies Press, Washington, DC
29. Nelson R.R. The market economy and the scientific commons. Research Policy 33 (2004) 455-471
30. Nelson R.R. Reflections on "The Simple Economics of Basic Scientific Research": looking back and looking forward. Industrial and Corporate Change 15 (2006) 903-917
31. Oosterwegel M.A., Greenwald R.J., Mandelbrot D.A., Lorsbach R.B., and Sharpe A.H. CTLA-4 and T cell activation. Current Opinion in Immunology 11 (1999) 294-300
32. Rynes S.L., Gerhart B., and Minette K.A. The importance of pay in employee motivation: discrepancies between what people say and what they do. Human Resource Management 43 (2004) 381-394
33. Sampat, B.N., 2004. Genomic patenting by academic researchers: bad for science? Presented at the roundtable on Engineering Entrepreneurship Research. Atlanta, GA.
34. Scotchmer S. Standing on the shoulders of giants: cumulative research and the patent law. Journal of Economic Perspectives 5 (1991) 29-41
35. Sen R., and Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46 (1986) 705-716
36. Shapiro C. Navigating the patent thicket: cross licenses, patent pools, and standard-setting. In: Jaffe A., Lerner J., and Stern S. (Eds). Innovation Policy and the Economy (2000), MIT Press, Cambridge 119-150
37. Thursby J.G., and Thursby M.C. University licensing and the Bayh-Dole Act. Science 301 (2003) 1052
38. Walsh J.P., Arora A., and Cohen W.M. Working through the patent problem. Science 299 (2003) 1020
39. Walsh J.P., and Hong W. Secrecy is increasing in step with competition. Nature 422 (2003) 801-802
40. Walsh, J.P., Cho, C., Cohen, W.M., 2005a. Patents, material transfers and access to research inputs in biomedical research. Final Report to the National Academy of Sciences' Committee on Intellectual Property Rights in Genomic and Protein-Related Inventions. http://tigger.uic.edu/∼jwalsh/NASReport.html.
41. Walsh J.P., Cho C., and Cohen W.M. The view from the bench: patents, material transfers and biomedical research. Science 309 (2005) 2002-2003
42. Yamamoto Y., and Gaynor R.B. Role of the NF-kappaB pathway in the pathogenesis of human disease states. Current Molecular Medicine 1 (2001) 287-296